After data reduction and analysis, results showed the low and high expression of RhoA and ROCK1 in Fig. 3b, and both RhoA and ROCK1 levels were significantly associated with lymph node metastasis and clinical stages (Fig. 3c). This evidence concerns the gene ROCK1 and metastatic malignant neoplasm in the lymph nodes.